Briley EM[au] - Search Results

Year	Number of Results
1990	1
1991	1
1992	1
1993	2
1994	1
1995	3
1996	1
1998	1
1999	1
2002	1
2009	2
2021	0

1

Muscarinic acetylcholine receptor subtypes associated with release of Alzheimer amyloid precursor derivatives activate multiple signal transduction pathways.

Felder CC, Ma AL, Briley EM, Axelrod J. Felder CC, et al. Among authors: briley em. Ann N Y Acad Sci. 1993 Sep 24;695:15-8. doi: 10.1111/j.1749-6632.1993.tb23020.x. Ann N Y Acad Sci. 1993. PMID: 8239275 Review.

2

Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

O'Connor JC, Lawson MA, André C, Briley EM, Szegedi SS, Lestage J, Castanon N, Herkenham M, Dantzer R, Kelley KW. O'Connor JC, et al. Among authors: briley em. J Immunol. 2009 Mar 1;182(5):3202-12. doi: 10.4049/jimmunol.0802722. J Immunol. 2009. PMID: 19234218 Free PMC article.

3

Muscarinic receptors mediate the release of arachidonic acid from spinal cord and hippocampal neurons in primary culture.

Kanterman RY, Ma AL, Briley EM, Axelrod J, Felder CC. Kanterman RY, et al. Among authors: briley em. Neurosci Lett. 1990 Oct 16;118(2):235-7. doi: 10.1016/0304-3940(90)90635-m. Neurosci Lett. 1990. PMID: 2125713

4

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL. Felder CC, et al. Among authors: briley em. Mol Pharmacol. 1995 Sep;48(3):443-50. Mol Pharmacol. 1995. PMID: 7565624

5

Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord.

Hohmann AG, Briley EM, Herkenham M. Hohmann AG, et al. Among authors: briley em. Brain Res. 1999 Mar 20;822(1-2):17-25. doi: 10.1016/s0006-8993(98)01321-3. Brain Res. 1999. PMID: 10082879

6

Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.

Kanterman RY, Mahan LC, Briley EM, Monsma FJ Jr, Sibley DR, Axelrod J, Felder CC. Kanterman RY, et al. Among authors: briley em. Mol Pharmacol. 1991 Mar;39(3):364-9. Mol Pharmacol. 1991. PMID: 1848657

7

Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.

Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, Felder CC. Priller J, et al. Among authors: briley em. Mol Pharmacol. 1995 Aug;48(2):288-92. Mol Pharmacol. 1995. PMID: 7651362

8

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.

Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA. Felder CC, et al. Among authors: briley em. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7656-60. doi: 10.1073/pnas.90.16.7656. Proc Natl Acad Sci U S A. 1993. PMID: 8395053 Free PMC article.

9

Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation.

Proescholdt MG, Chakravarty S, Foster JA, Foti SB, Briley EM, Herkenham M. Proescholdt MG, et al. Among authors: briley em. Neuroscience. 2002;112(3):731-49. doi: 10.1016/s0306-4522(02)00048-9. Neuroscience. 2002. PMID: 12074914

10

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW. Felder CC, et al. Among authors: briley em. FEBS Lett. 1996 Sep 16;393(2-3):231-5. doi: 10.1016/0014-5793(96)00891-5. FEBS Lett. 1996. PMID: 8814296 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results